What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Peter O’Callaghan, PhD, Head of Expression System Sciences, Biologics and Licensing, Lonza, on: ‘Solve bispecific heavy-light chain mispairing with bYlok technology’. Paul Dyer, PhD, Field Application Scientist, Halo Labs, on: ‘Total particle analysis with aura; pathway to USP validation and product release’.
52 
Let's personalize your content